The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Osteoporosis, Surgery and Rheumatology. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Physical therapy. The concepts of his Rheumatoid arthritis study are interwoven with issues in Connective tissue disease, Methotrexate, Infliximab and Arthritis.
Willem F. Lems has researched Osteoporosis in several fields, including N-terminal telopeptide, Placebo, Ankylosing spondylitis and Bone remodeling. His Surgery study incorporates themes from Combination therapy and Cohort. His Rheumatology research includes elements of Erythrocyte sedimentation rate and Oncology.
Internal medicine, Rheumatoid arthritis, Physical therapy, Osteoarthritis and Osteoporosis are his primary areas of study. In Internal medicine, he works on issues like Surgery, which are connected to Functional ability. His work deals with themes such as Methotrexate, Infliximab, Disease and Combination therapy, which intersect with Rheumatoid arthritis.
His work carried out in the field of Physical therapy brings together such families of science as Body mass index, Randomized controlled trial, Exercise therapy and Comorbidity. Muscle strength is closely connected to Cohort in his research, which is encompassed under the umbrella topic of Osteoarthritis. His Osteoporosis research is multidisciplinary, incorporating elements of Incidence and Bone remodeling.
His main research concerns Internal medicine, Osteoarthritis, Rheumatoid arthritis, Physical therapy and Osteoporosis. His study in Osteoarthritis is interdisciplinary in nature, drawing from both Knee Joint, Physical medicine and rehabilitation and Cohort. Rheumatoid arthritis is a subfield of Immunology that Willem F. Lems tackles.
In his work, WOMAC is strongly intertwined with Body mass index, which is a subfield of Physical therapy. His Osteoporosis research incorporates elements of Ankylosing spondylitis, Bone remodeling and Intensive care medicine. His Rheumatology research includes themes of Bone mineral and Orthopedic surgery.
His main research concerns Internal medicine, Rheumatoid arthritis, Osteoporosis, Disease and Osteoarthritis. His studies link Endocrinology with Internal medicine. His work on Antirheumatic Agents is typically connected to Cobra as part of general Rheumatoid arthritis study, connecting several disciplines of science.
His Osteoporosis research incorporates themes from Zoledronic acid, Ankylosing spondylitis, Bone remodeling and Urology. His Osteoarthritis research is multidisciplinary, incorporating perspectives in Degeneration, Physical therapy and Clinical psychology. Willem F. Lems has included themes like Discontinuation, Randomized controlled trial, Surgery, Pharmacotherapy and Vitamin D and neurology in his Arthritis study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben.
Arthritis & Rheumatism (2005)
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.
Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg.
JAMA (2011)
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel.
Annals of the Rheumatic Diseases (2007)
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl.
Arthritis & Rheumatism (2006)
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation
V P van Halm;M J L Peters;A E Voskuyl;M Boers.
Annals of the Rheumatic Diseases (2009)
Does Rheumatoid Arthritis Equal Diabetes Mellitus as an Independent Risk Factor for Cardiovascular Disease? A Prospective Study
Mike J. L. Peters;Vokko P. van Halm;Alexandre E. Voskuyl;Yvo M. Smulders.
Arthritis & Rheumatism (2009)
Republished: Value of biomarkers in osteoarthritis: current status and perspectives
M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi.
Postgraduate Medical Journal (2014)
Value of biomarkers in osteoarthritis: current status and perspectives
M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi.
Annals of the Rheumatic Diseases (2013)
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M Vis;E A Havaardsholm;G Haugeberg;T Uhlig.
Annals of the Rheumatic Diseases (2006)
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven O Stapel.
Annals of the Rheumatic Diseases (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vrije Universiteit Amsterdam
University of Amsterdam
Vrije Universiteit Amsterdam
Maastricht University
Vrije Universiteit Amsterdam
Amsterdam UMC
Vrije Universiteit Amsterdam
University of Southampton
VU University Medical Center
University of Jyväskylä
Polytechnic University of Milan
University of Reading
Michigan State University
University of Wisconsin–Madison
Chalmers University of Technology
Indian Institute of Technology Kharagpur
Hokkaido University
University of Melbourne
National Institutes of Health
University of Florida
Kagawa University
Universidade de Vigo
Washington University in St. Louis
Cedars-Sinai Medical Center
Brigham and Women's Hospital